Tag: European Medicines Agency

September 11, 2021 0

AK-OTOF to treat otoferlin gene-mediated hearing loss in EU

By Team FM

The European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) issued a positive opinion on the application for orphan drug designation for AK-OTOF, a gene therapy intended for the treatment of otoferlin gene-mediated hearing loss, Akouos, Inc announced.